FRMO CORP
FRMO
The9 Ltd
NCTY
Argo Blockchain
ARBK
Ebang International
EBON
Intchains Group
ICG
Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded by Dror Mevorach on January 22, 2012 and is headquartered in Ness Ziona, Israel.